HOME >> BIOLOGY >> NEWS
Cancer research finds targets for new cholesterol-lowering therapies

(Uppsala, June 7th) -- A team of investigators from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) and Harvard Medical School has uncovered novel targets for the development of drugs that would potentially complement, or replace, statins in treating heart disease.

Statins are commonly taken drugs that reduce the levels of low density lipoprotein (LDL) and have been shown to reduce risks associated with heart disease, the number one killer in the Western world. However, statins are not suitable for all patients, and reduce cardiovascular events by only 20%- 40%. Additionally, some genetic causes of high cholesterol cannot be treated with statins.

According to LICR's Dr. Johan Ericsson, the senior author of the study published today in Cell Metabolism, the team found that a protein called Fbw7 degrades the SREBP proteins that drive lipid and cholesterol production. "We found that inhibiting Fbw7 resulted in increased SREBP levels and an enhanced uptake of LDL, so a drug that blocks the interaction between Fbw7 and SREBP proteins would probably enhance the removal of harmful LDL-cholesterol from the circulation. We can only speculate at this stage, but a two-pronged attack on LDL removal, combining a statin with a treatment that prevents Fbw7/SREBP interaction would likely be of more benefit to some patients than statins alone."

Dr. Ericsson said that the team also found that the Fbw7/SREBP interaction may also be connected to diabetes, as insulin signaling inhibited Fbw7's ability to affect SREBP levels and thus increased lipid and cholesterol synthesis. Finally, the Fbw7/SREBP interaction also provides a theoretical link between lipid synthesis and the aberrant growth of cancer cells. The loss of Fbw7, which is inactivated in some breast, endometrial, ovarian and colon cancers, has been shown to make cells multiply faster and synthesize more lipids; factors that are critical for tumor growth. Aspects of both links are u
'"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
1-917-974-7952
Ludwig Institute for Cancer Research
7-Jun-2005


Page: 1 2

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. The Cancer Genome Atlas awards funds for technology development
4. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
5. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
6. Cancer stem cells can go it alone
7. Cancer drug enhances long-term memory
8. Cancer cells reprogram energy needs to grow and spread, study suggests
9. Cancer scientists create human leukemia process to map how disease begins, progresses
10. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
11. Other highlights from the April 18 Journal of the National Cancer Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/1/2018)... , ... October 01, 2018 , ... ... targeted antibody drug conjugate (ADC) like, lipid based therapeutics, today announced the ... Program had confirmed the award of first year funding for two separate grants. ...
(Date:10/1/2018)... SAN JOSE, Calif. (PRWEB) , ... October 01, ... ... Station, Trinity, Ascension, MDLIVE and 1200+ customers and InteloMed, the leading patient monitoring ... providers to capture vital signs and other indications of patient health during a ...
(Date:9/29/2018)... ... September 29, 2018 , ... ... of Life Science companies. The in-person briefings are expected to transform Medical Affairs, ... is bringing to the U.S. healthcare market—especially to individuals, employers, and other healthcare ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... EWING, N.J. (PRWEB) , ... September 26, 2018 ... ... and DNA testing are way ahead of their primary care physicians, according to ... , For this study, patients and doctors were asked about consumer adoption of ...
(Date:9/24/2018)... ... September 24, 2018 , ... ReGrow Helmet , the most ... and most affordable option for hair regrowth in the comfort of one’s home. Early ... 2, 2018. , The sophisticated design and advanced technology of the ReGrow Helmet ...
(Date:9/15/2018)... ... 14, 2018 , ... Nationally recognized public accounting and consulting firm Cherry ... of the Firm’s Nashville practice, on her appointment to Launch Tennessee’s Board ... named Managing Partner of the Firm’s Nashville practice in December 2017 . In this ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... quality management professional and former Senior Director of Regulatory Affairs and Quality Systems ... As Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., she ...
Breaking Biology Technology:
Cached News: